Rakesh Dahiya
Thursday, January 27, 2022
CDSCO gives nod to Sun Pharma for phase III clinical trial for antipsychotic drug Pimavanserin
https://thehealthmaster.com/?p=34539
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment